We are pleased to announce the 20th International Symposium on NeuroVirology held jointly with the 2025 Conference on HIV in the Nervous System on June 2-5, 2025 at the Westin Denver Downtown in Denver, Colorado, USA. Please check this page in the near future for more information. Meeting Overview This four-day Symposium will feature presentations from leading experts in these areas of interest below. New Technologies/Initiatives Role of Viruses in Aging/Dementias and Psychiatric Disorders Virus-associated Chronic Conditions Herpesviruses and Neurological Diseases Global Neurovirology/Re-emerging Pathogens HIV Persistence, Therapy and Cure in the Brain Exosomes - Biomarkers and Therapy NeuroHIV and Co-morbidities (including DOA) Artificial Intelligence in Science and Medicine Multimodal Integrated Analysis and Assessment Development for NeuroHIV Outcomes (MIADD) - Brain health disorders (BHDs) affect a substantial proportion of people with HIV (PWH), including those who achieve viral suppression with antiretroviral therapy (ART). Unfortunately, there is significant heterogeneity in the clinical expression of BHDs among PWH, which hampers prevention and treatment efforts. This symposium introduces the MIAAD-NHIV project, a multi-national collaborative effort to leverage prior and ongoing NIH-sponsored research projects to better understand the heterogeneity of BHDs in PWH on suppressive ART using data from established cohorts and advanced analytic strategies, including machine learning and inferential methods. The results have potential to identify actionable mechanisms underlying complex clinical expressions of BHDs in PWH. The session will review the conceptual underpinnings of the project, the design and analytic strategy (including potential pitfalls and alternatives), and preliminary findings.

Local Organizing Committee

ISNV Meetings Committee